ArticleFrontiers in immunology2026
TLR4/NF-κB signaling-mediated neuroinflammation is associated with gut microbiota dysbiosis in a mouse model of Parkinson's disease.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Melatonin Partially Attenuates Oxycodone-Induced Placental Stress Signaling and Fetal Brain Apoptosis in a Sex-Specific Manner.bioRxiv : the preprint server for biology · 2026Article
- Acupuncture regulates neuroinflammation: microglial glucose metabolism reprogramming as a potential mediating mechanism.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Dysbiosis of the microbiota-gut-brain axis contribute to the neurodegenerative process of Parkinson's disease (PD), and dysbiosis and inflammatory responses represent key mechanisms. This study aims to explore the structural changes in the composition of the gut microbiota and the alterations in the inflammatory response mediated by the TLR4/NF-κB pathway in a rotenone-induced PD mouse model, as well as the correlation between the two. Methods: The motor coordination and spontaneous locomotor activity of the PD mouse model were evaluated using the Rota-Rod test, pole climbing test and open field test. The expression of α-synuclein (α-syn) and the activation status of the TLR4/NF-κB pathway were analyzed by western blot, quantitative real-time polymerase chain reaction (RT-qPCR) combined with immunohistochemistry. Enzyme-linked immunosorbent assay (ELISA) was used to quantitatively detect the levels of LPS and pro-inflammatory indicators TNF-α, IL-1β and IL-6. The diversity, composition structure and differential abundance of the gut microbiota were analyzed by 16S rRNA sequencing, and correlation analysis was conducted between some microbiota and inflammatory indicators related to the activation of the TLR4/NF-κB signaling pathway. Results: Mechanistic investigation revealed that rotenone activated the TLR4/NF-κB signaling pathway in the midbrain substantia nigra (SN) and colon tissues, accompanied by a significant increase in LPS levels and pro-inflammatory indicators. 16S rRNA sequencing analysis revealed that the alpha diversity of the gut microbiota were reduced in the model group, the beta diversity structure was altered. In terms of microbiota composition, at the phylum level, the relative abundance of Bacteroidota decreased, while Actinobacteria and Tenericutes increased. At the family level, the relative abundance of Conclusion: This study demonstrates a key role of the TLR4/NF-κB signaling pathway in the microbiota-gut-brain axis of a rotenone-induced PD mouse model, where gut microbiota dysbiosis exhibits a significant correlation with inflammation induced by TLR4/NF-κB activation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.